Mimura, Kousaku <br/><br/>
The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Dec 2013 
 - 6261-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1550-6606 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.1301597  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstadienes--pharmacology<br/>Antigen Presentation--genetics<br/>Antigens, Neoplasm--biosynthesis<br/>Cell Line, Tumor<br/>Epidermal Growth Factor--pharmacology<br/>ErbB Receptors--antagonists & inhibitors<br/>Esophageal Neoplasms--genetics<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Flavonoids--pharmacology<br/>Gene Expression Regulation, Neoplastic--physiology<br/>Genes, MHC Class I<br/>HLA-A Antigens--biosynthesis<br/>Humans<br/>Lapatinib<br/>MAP Kinase Signaling System--drug effects<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Phosphorylation--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Processing, Post-Translational--drug effects<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Quinazolines--pharmacology<br/>RNA, Small Interfering--pharmacology<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Stomach Neoplasms--genetics<br/>Wortmannin